Study ID: GA 9010
Study Title
- Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to ClinicFemale, Maley Definite Multiple Sclerosis of Subjects Presenting With ClinicFemale, Maley Isolated Syndrome
Teva Identifier
- GA 9010
ClinicalTrials.gov Identifier
- NCT00666224
Study Status
- Completed
Trial Condition(s)
- Multiple Sclerosis
Interventions
- Drug: Glatiramer Acetate (DB)|Drug: Placebo | Drug: Glatiramer Acetate (OL)
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 45 Years
Trial Duration
- 01/01/2004 - 06/01/2010
Phase
- Phase 3
Study Type
Interventional